Pulmonary toxicity of mitomycin

68Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Six patients with breast cancer developed pulmonary toxicity following mitomycin therapy. The presenting symptoms were shortness of breath and a dry cough. The radiological pictures varied from a normal chest x‐ray to extensive bilateral pneumonitis. The histological findings consisted of diffuse alveolar damage progressing to interstitial pulmonary fibrosis. Corticosteroid therapy resulted in complete resolution of pneumonia in one patient. Respiratory symptoms improved in 3 patients following discontinuation of the drug. Two patients with extensive bilateral pneumonitis, who were not treated with steriods, died of respiratory failure. Mitomycin‐induced lung toxicity appears to be reversible with the discontinuation of drug and the administration of corticosteroids. Lung biopsy is necessary in order to rule out other diagnoses. Copyright © 1980 American Cancer Society

Cite

CITATION STYLE

APA

Buzdar, A. U., Legha, S. S., Luna, M. A., Tashima, C. K., Hortobagyi, G. N., & Blumenschein, G. R. (1980). Pulmonary toxicity of mitomycin. Cancer, 45(2), 236–244. https://doi.org/10.1002/1097-0142(19800115)45:2<236::AID-CNCR2820450207>3.0.CO;2-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free